Short answer · Medically reviewed summary · Last updated: 2026-04-07
Fibrous dysplasia is a rare skeletal disorder where normal bone is replaced by fibrous tissue, first formally characterized in the medical literature in the 1930s. Since its initial identification, our understanding of fibrous dysplasia has shifted from viewing it as a localized bone tumor to recognizing it as a complex genetic condition caused by post-zygotic mutations in the GNAS gene. When and how was fibrous dysplasia first described? While isolated cases of bone deformities were noted in surgical texts in the late 19th century, fibrous dysplasia was not formally defined as a distinct clinical entity until 1937.
4 people with Fibrous Dysplasia have shared their first-person experience on this question at DiseaseMaps.
What is the history of Fibrous Dysplasia?
History of Fibrous Dysplasia: when and how it was discovered, and the milestones in research since, medically reviewed.
Fibrous dysplasia is a rare skeletal disorder where normal bone is replaced by fibrous tissue, first formally characterized in the medical literature in the 1930s. Since its initial identification, our understanding of fibrous dysplasia has shifted from viewing it as a localized bone tumor to recognizing it as a complex genetic condition caused by post-zygotic mutations in the GNAS gene.
When and how was fibrous dysplasia first described?
While isolated cases of bone deformities were noted in surgical texts in the late 19th century, fibrous dysplasia was not formally defined as a distinct clinical entity until 1937. Physicians Lichtenstein and Jaffe are credited with synthesizing the clinical and radiological features of the condition, distinguishing it from other skeletal diseases like hyperparathyroidism. Before this, the medical community often misdiagnosed fibrous dysplasia lesions as solitary bone cysts or even malignant tumors, leading to aggressive and often unnecessary surgical interventions.
How has our understanding of the disease evolved?
In the mid-20th century, researchers identified that fibrous dysplasia could exist in two primary forms: monostotic (affecting one bone) and polyostotic (affecting multiple bones). A major turning point occurred in 1991 when researchers discovered that the condition is caused by a somatic mutation in the GNAS gene. Because this mutation occurs after fertilization (post-zygotic), fibrous dysplasia is not inherited from parents, but rather occurs sporadically during development. This scientific breakthrough corrected the historical misconception that the condition was an inherited skeletal malformation.
What are the major milestones in treatment and diagnosis?
The management of fibrous dysplasia has evolved from radical surgery to a more nuanced approach focused on symptom management and orthopedic stabilization. Key milestones include:
- 1937: First comprehensive clinical description by Lichtenstein and Jaffe.
- 1960s-70s: Improved imaging techniques allowed for better differentiation between benign fibrous lesions and osteosarcoma.
- 1991: Identification of the GNAS gene mutation, moving the field into the era of molecular diagnostics.
- 2000s-Present: Introduction of bisphosphonate therapy to manage bone pain and the development of specialized orthopedic techniques to minimize fracture risk.
How have patient advocacy and community support changed the landscape?
For decades, patients with fibrous dysplasia faced isolation due to the rarity of the condition and the lack of specialized care centers. Today, the landscape is transformed by digital platforms like DiseaseMaps.org, where 280 people with fibrous dysplasia have connected to share their lived experiences. This community-driven data is invaluable, helping researchers understand the real-world impact of pain, mobility challenges, and the psychological burden of a chronic diagnosis, which clinical literature alone cannot capture.
Next steps
- Consult an orthopedic oncologist or an endocrinologist specializing in metabolic bone disease.
- Request a referral to a center of excellence that manages fibrous dysplasia to ensure multidisciplinary care.
- Connect with the community at DiseaseMaps.org to share experiences and learn from others living with the condition.
- Monitor bone health through regular screenings and imaging as recommended by your specialist.
Medical disclaimer: This content is for informational purposes only and does not constitute professional medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.
References
- NIH Genetic and Rare Diseases Information Center (GARD): Fibrous Dysplasia.
- Orphanet: Monostotic and Polyostotic Fibrous Dysplasia.
- OMIM (Online Mendelian Inheritance in Man): GNAS gene and Fibrous Dysplasia (#174800).
- The Fibrous Dysplasia Foundation: Patient Education and Research Resources.
What Is Fibrous Dysplasia?
Fibrous dysplasia (FD) is a skeletal disorder in which bone-forming cells fail to mature and produce too much fibrous, or connective, tissue. Areas of healthy bone are replaced with this fibrous tissue. The replacement of normal bone in fibrous dysplasia can lead to pain, misshapen bones, and fracture, especially when it occurs in the long bones (arms and legs). When it occurs in the skull, there can also be a replacement of the normal bone with fibrous tissue, resulting in changes in the shape of the face or skull, pain, and, in rare circumstances, hearing or vision loss.
Some people with fibrous dysplasia have only one bone involved (monostotic), whereas other people have more than one bone involved (polyostotic). The disease may occur alone, or as part of a condition known as the McCune-Albright syndrome. McCune-Albright syndrome is characterized by fibrous dysplasia and other symptoms such as patches of pigmented skin (light brown or “café-au-lait” spots) and endocrine problems such as early puberty (precocious puberty), hyperthyroidism (excess thyroid hormone), excess growth hormone (gigantism or acromegaly), excess cortisol (Cushing’s syndrome), and other rare conditions.
Fibrous dysplasia can affect any bone in the body. The most common sites are the bones in the skull and face, femur (thighbone), tibia (shinbone), humerus (upper arm), pelvis, and ribs. Although many bones can be affected at once—and affected bones are often found on one side of the body—the disease does not “spread” from one bone to another; that is, the pattern of which bones are involved is established very early in life and does not change with age.
Posted Jun 9, 2017 by Lisa Hill 2050
Posted Jul 21, 2017 by Debra 2000
Posted Oct 7, 2017 by Kiesha brown 3050
I don't know the history, just researching right now. This condition was first described in 1942 by Lichtenstein and Jaffe hence, fibrous dysplasia is sometimes referred to as Lichtenstein-Jaffe disease.
Posted Oct 23, 2020 by anna_d09 2500
